Verrica Pharmaceuticals (VRCA) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

VRCA is expected to report earnings to rise 1.43% to -37 cents per share on November 07

Verrica Pharmaceuticals VRCA Stock Earnings Reports

Q3'24

Est.

$-0.38

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.05

Q4'23

Beat

by $0.03

Q3'23

Missed

by $0.18

The last earnings report on August 14 showed earnings per share of -37 cents, beating the estimate of -40 cents. With 373.74K shares outstanding, the current market capitalization sits at 72.11M.

View a ticker or compare two or three

Compare

VRCA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VRCA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

44 West Gay Street

Phone

+1 484 453-3300

Employees

100

Web

https://www.verrica.com